No, it's really a good deal. You will see once Al's secret plan for the future is revealed over time. If he lives that long. Hopefully, he'll reveal secret plan before he goes to bio-tech heaven.
Why don't you go do some freelance reporting from Irak or Syria? Certainly better your head than those good people with noble hearts who were killed by your brothers in thought there...
I know... there, there now. It's okay. MannKind raking in $1-$3 Billion annually for the next twenty years for having invested $2 Billion doesn't sound fair at all, anymore than $35-$45/share by 2017 or $75-$95/share by 2019 doesn't sound fair for MNKD shareholders. I sure wish Al had sent you in there to negotiate with Sanofi.
Sentiment: Strong Buy